Data Element
Description and Corresponding CTRP PA Data Element Where Applicable
Biomarker Name
The name of the biomarker as indicated in the Protocol document.
Biomarker Use
(CDE ID 2939411)
A value that describes the biomarker use. Valid values include:
Biomarker Purpose
(CDE ID 2939397)
A value that describes the reason or intention of the biomarker in the clinical study. Valid values include:
NCI ID
The
NCT ID
The
Lead Org ID
The
Phase
The For information, refer to Trial Phase Value Definitions, Abstracting Interventional Trial Design, or Abstracting Non-Interventional Trial Design.
The anatomic site terms that identify the anatomic cancer site(s) on which a trial or study is focused. For information, refer to Data Table 4 Anatomic Site Values or Abstracting Data Table 4 Anatomic Sites. When a trial has multiple disease sites, the report uses a semicolon (;) to separate values.
Official Title
The For information, refer to Abstracting Trial Descriptions, Titles, and Identifiers.
Current Trial Overall Status
The For details, refer to Trial Status Values in the CTRP and ClinicalTrials.gov and Abstracting Trial Statuses.
Processing Status
The For information, refer to Trial Processing Statuses and Abstracting Trial Statuses.
The standard name used to refer to an intervention. For drugs, this is the generic name. For investigational new drugs that do not yet have a generic name, this may be the chemical name, company code, or serial number. For information, refer to Abstracting Interventions. When a trial has multiple intervention names, the report uses a semicolon (;) to separate values.
The mode of intervention, for example, drug or device. For information, refer to Abstracting Interventions. When a trial has multiple intervention types, the report uses a semicolon (;) to separate values.